We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

77 hedge funds and large institutions have $127M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 84 → 77 (-7)

23% less capital invested

Capital invested by funds: $164M → $127M (-$37.3M)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

Holders
77
Holders Change
-7
Holders Change %
-8.33%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
41
Reduced
14
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
+$2.72M
2
MMH
Menora Mivtachim Holdings
Israel
+$2.22M
3
OM
Opaleye Management
Massachusetts
+$2.04M
4
TCM
Tekla Capital Management
Massachusetts
+$2.04M
5
Northern Trust
Northern Trust
Illinois
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$7.93M
2
PCM
Pentwater Capital Management
Florida
-$2.04M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.03M
4
GTC
Ghost Tree Capital
New York
-$1.02M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$787K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
26
BlackRock Institutional Trust
California
$1.33M +$152K +14,912 +9%
FCM
27
Farallon Capital Management
California
$1.25M +$9.17K +900 +0.5%
Millennium Management
28
Millennium Management
New York
$1.16M +$1.34M +131,518 +489%
GTC
29
Ghost Tree Capital
New York
$1.1M -$1.02M -100,000 -40%
PVI
30
Pura Vida Investments
New York
$748K +$1.04M +102,000 New
MC
31
Menta Capital
California
$673K +$50K +4,902 +6%
BIM
32
BlackRock Investment Management
Delaware
$608K +$16.3K +1,601 +2%
TCIM
33
TIAA CREF Investment Management
New York
$558K +$137K +13,465 +21%
Deutsche Bank
34
Deutsche Bank
Germany
$524K +$202K +19,797 +38%
PC
35
PointState Capital
New York
$495K +$688K +67,500 New
NI
36
Numeric Investors
Massachusetts
$488K +$402K +39,400 +145%
Neuberger Berman Group
37
Neuberger Berman Group
New York
$458K -$287K -28,200 -31%
Vanguard Group
38
Vanguard Group
Pennsylvania
$457K +$229K +22,438 +56%
Federated Hermes
39
Federated Hermes
Pennsylvania
$440K – – –
DCM
40
Decade Capital Management
New York
$440K +$611K +60,000 New
RFC
41
Russell Frank Company
Washington
$439K -$101K -9,924 -14%
PP
42
PDT Partners
New York
$426K -$12.1K -1,184 -2%
LOAMU
43
Lombard Odier Asset Management (USA)
New York
$379K +$347 +34 +0.1%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$302K -$1.02K -100 -0.2%
TA
45
Teachers Advisors
New York
$241K – – –
Charles Schwab
46
Charles Schwab
California
$238K – – –
Geode Capital Management
47
Geode Capital Management
Massachusetts
$235K +$43.4K +4,254 +15%
Goldman Sachs
48
Goldman Sachs
New York
$183K -$30.9K -3,032 -11%
Morgan Stanley
49
Morgan Stanley
New York
$163K +$31.3K +3,069 +16%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$156K -$212K -20,754 -49%
1
2
3 4

FOMX Hedge Fund Activity: Q3 2015 in Review

77 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q3 2015, worth a combined $127M — down 23% from $164M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of FOMX and 7 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 41 added.

The largest buyer was Cadian Capital Management, opening a new position worth an estimated $2.72M. The largest seller was Visium Asset Management, exiting entirely with an estimated $7.93M sold.

  • 77 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q3 2015, down from 84 in Q2 2015.
  • Funds reported $127M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q3 2015, down 23% quarter-over-quarter.
  • 7 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q3 2015 and 14 closed out, a net change of -7 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q3 2015 was Cadian Capital Management, an estimated $2.72M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q3 2015 was Visium Asset Management, an estimated $7.93M sold.

Based on aggregated 13F filings for Q3 2015.